Skip to main content
SpringerLink
Log in

Autonomic Nervous System Modulation of the Epicardial Adipose Tissue in Heart Failure and Atrial Fibrillation

  • Chapter
  • First Online:
Epicardial Adipose Tissue

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 480 Accesses

Abstract

The epicardial adipose tissue (EAT) or epicardial fat, the visceral fat depot in the heart, contains intrinsic adrenergic and cholinergic nerves, which interact with the extrinsic cardiac sympathetic and parasympathetic nervous systems. These EAT nerves represent a significant source of several adipokines and other bioactive molecules, including norepinephrine and epinephrine. The production of these molecules is biologically relevant for the heart, because abnormalities in EAT secretory properties are implicated in the development of pathological conditions, including coronary atherosclerosis, atrial fibrillation, and heart failure. Because sympathetic hyperactivity and parasympathetic (cholinergic) derangement are associated with EAT dysfunction leading to a multitude of adverse cardiac conditions, such as heart failure, diastolic dysfunction, atrial fibrillation, etc., a number of recent studies have focused on exploring the autonomic regulation of EAT as it pertains to heart disease pathogenesis and progression. In this chapter, we provide an overview of these studies, immediately following brief introductions on the regulation of global cardiac function by the two branches of the autonomic nervous system (adrenergic and cholinergic).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J. 2017;38:1294–302.

    Article  CAS  PubMed  Google Scholar 

  2. Lymperopoulos A, Koch WJ. Autonomic pharmacology. In: Waldman SA, Terzic A, editors. Pharmacology and therapeutics: principles to practice. Philadelphia: Saunders/Elsevier; 2009. p. 115–39.

    Chapter  Google Scholar 

  3. Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev. 1999;51:651–90.

    CAS  PubMed  Google Scholar 

  4. Lymperopoulos A. Introduction/general considerations. In: Lymperopoulos A, editor. The cardiovascular adrenergic system. New York: Springer International Publishing; 2015. p. 3–9.

    Google Scholar 

  5. Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res. 2013;113:739–53.

    Article  CAS  PubMed  Google Scholar 

  6. Capote LA, Mendez Perez R, Lymperopoulos A. GPCR signaling and cardiac function. Eur J Pharmacol. 2015;763:143–8.

    Article  CAS  PubMed  Google Scholar 

  7. Lymperopoulos A, Garcia D, Walklett K. Pharmacogenetics of cardiac inotropy. Pharmacogenomics. 2014;15:1807–21.

    Article  CAS  PubMed  Google Scholar 

  8. Lymperopoulos A, Bathgate A. Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown. Pharmacogenomics. 2012;13:323–41.

    Article  CAS  PubMed  Google Scholar 

  9. Lymperopoulos A, Rengo G, Koch WJ. Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation. Trends Mol Med. 2007;13:503–11.

    Article  CAS  PubMed  Google Scholar 

  10. Lymperopoulos A. Ischemic emergency? endothelial cells have their own “adrenaline shot” at hand. Hypertension. 2012;60:12–4.

    Article  CAS  PubMed  Google Scholar 

  11. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, et al. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 1994;46(2):121–36.

    CAS  PubMed  Google Scholar 

  12. Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmacol Ther. 1993;60:405–30.

    Article  CAS  PubMed  Google Scholar 

  13. Yoshikawa T, Port JD, Asano K, Chidiak P, Bouvier M, Dutcher D, et al. Cardiac adrenergic receptor effects of carvedilol. Eur Heart J. 1996;17(Suppl B):8–16.

    Article  CAS  PubMed  Google Scholar 

  14. Woodcock EA, Du XJ, Reichelt ME, Graham RM. Cardiac alpha 1-adrenergic drive in pathological remodelling. Cardiovasc Res. 2008;77:452–62.

    Article  CAS  PubMed  Google Scholar 

  15. Shannon R, Chaudhry M. Effect of alpha1-adrenergic receptors in cardiac pathophysiology. Am Heart J. 2006;152:842–50.

    Article  CAS  PubMed  Google Scholar 

  16. Philipp M, Hein L. Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol Ther. 2004;101:65–74.

    Article  CAS  PubMed  Google Scholar 

  17. Philipp M, Brede M, Hein L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol. 2002;283:R287–95.

    Article  CAS  PubMed  Google Scholar 

  18. Hein L, Altman JD, Kobilka BK. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature. 1999;402:181–4.

    Article  CAS  PubMed  Google Scholar 

  19. Lymperopoulos A, Rengo G, Funakoshi H, Eckhart AD, Koch WJ. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med. 2007;13:315–23.

    Article  CAS  PubMed  Google Scholar 

  20. Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn GW II, Koch WJ. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. J Biol Chem. 2010;285:16378–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Lymperopoulos A, Rengo G, Zincarelli C, Soltys S, Koch WJ. Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity. Mol Ther. 2008;16:302–7.

    Article  CAS  PubMed  Google Scholar 

  22. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol. 2008;70:23–49.

    Article  CAS  PubMed  Google Scholar 

  23. Skeberdis VA, Gendviliene V, Zablockaite D, Treinys R, Macianskiene R, Bogdelis A, et al. Beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current. J Clin Invest. 2008;118(9):3219–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 1998;102(7):1377–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Roy A, Guatimosim S, Prado VF. Cholinergic activity as a new target in diseases of the heart. Mol Med. 2015;20:527–37.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hartzell HC. Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems. Prog Biophys Mol Biol. 1988;52:165–247.

    Article  CAS  PubMed  Google Scholar 

  27. Li DL, Liu BH, Sun L, Zhao M, He X, Yu XJ, Zang WJ. Alterations of muscarinic acetylcholine receptors-2, 4 and alpha7-nicotinic acetylcholine receptor expression after ischaemia/reperfusion in the rat isolated heart. Clin Exp Pharmacol Physiol. 2010;37:1114–9.

    Article  CAS  PubMed  Google Scholar 

  28. Anderson A, Kulkarni K, Marron Fernandez de Velasco E, Carlblom N, Xia Z, Nakano A, et al. Expression and relevance of the G protein-gated K+ channel in the mouse ventricle. Sci Rep. 2018;8:1192.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Giles W, Noble SJ. Changes in membrane currents in bullfrog atrium produced by acetylcholine. J Physiol. 1976;261(1):103–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Dhein S, van Koppen CJ, Brodde OE. Muscarinic receptors in the mammalian heart. Pharmacol Res. 2001;44:161–82.

    Article  CAS  PubMed  Google Scholar 

  31. Caulfield MP. Muscarinic receptors--characterization, coupling and function. Pharmacol Ther. 1993;58:319–79.

    Article  CAS  PubMed  Google Scholar 

  32. Agarwal SK, Norby FL, Whitsel EA, Soliman EZ, Chen LY, Loehr LR, et al. Autonomic dysfunction and incidence of atrial fibrillation: results from 20 years follow-up. J Am Coll Cardiol. 2017;69:291–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Jungen C, Scherschel K, Eickholt C, Kuklik P, Klatt N, Bork N, et al. Disruption of cardiac cholinergic neurons enhances susceptibility to ventricular arrhythmias. Nat Commun. 2017;8:14155.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. González SA, Forcada P, de Cavanagh EM, Inserra F, Svane JC, Obregón S, et al. Sodium intake is associated with parasympathetic tone and metabolic parameters in mild hypertension. Am J Hypertens. 2012;25:620–4.

    Article  PubMed  CAS  Google Scholar 

  35. McAreavey D, Neilson JM, Ewing DJ, Russell DC. Cardiac parasympathetic activity during the early hours of acute myocardial infarction. Br Heart J. 1989;62:165–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Lombardi F, Sandrone G, Spinnler MT, Torzillo D, Lavezzaro GC, Brusca A, Malliani A. Heart rate variability in the early hours of an acute myocardial infarction. Am J Cardiol. 1996;77:1037–44.

    Article  CAS  PubMed  Google Scholar 

  37. Grassi G, Seravalle G, Bertinieri G, Turri C, Stella ML, Scopelliti F, Mancia G. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Clin Sci (Lond). 2001;101:141–6.

    Article  CAS  Google Scholar 

  38. Hellermann JP, Jacobsen SJ, Redfield MM, Reeder GS, Weston SA, Roger VL. Heart failure after myocardial infarction: clinical presentation and survival. Eur J Heart Fail. 2005;7:119–25.

    Article  PubMed  Google Scholar 

  39. Lara A, Damasceno DD, Pires R, Gros R, Gomes ER, Gavioli M, et al. Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol. 2010;30:1746–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Gerber Y, Weston SA, Enriquez-Sarano M, Manemann SM, Chamberlain AM, Jiang R, Roger VL. Atherosclerotic burden and heart failure after myocardial infarction. JAMA Cardiol. 2016;1:156–62.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Zhou Q, Zhang L, Wang K, Xu X, Ji M, Zhang F, Wang H, Hou Y. Effect of interconnection between cervical vagus trunk, epicardial fat pad on sinus node function, and atrial fibrillation. Pacing Clin Electrophysiol. 2014;37:356–63.

    Article  PubMed  Google Scholar 

  42. Pabon MA, Manocha K, Cheung JW, Lo JC. Linking arrhythmias and adipocytes: insights, mechanisms, and future directions. Front Physiol. 2018;9:1752.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 1996;7:999–1007.

    Article  CAS  PubMed  Google Scholar 

  44. Zipes DP, Knope RF. Electrical properties of the thoracic veins. Am J Cardiol. 1972;29:372–6.

    Article  CAS  PubMed  Google Scholar 

  45. Harvey RD, Belevych AE. Muscarinic regulation of cardiac ion channels. Br J Pharmacol. 2003;139:1074–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Pollard CM, Desimine VL, Wertz SL, Perez A, Parker BM, Maning J, et al. Deletion of osteopontin enhances β2-adrenergic receptor-dependent anti-fibrotic signaling in cardiomyocytes. Int J Mol Sci. 2019;20:E1396.

    Article  PubMed  CAS  Google Scholar 

  47. Rosenshtraukh LV, Zaitsev AV, Fast VG, Pertsov AM, Krinsky VI. Vagally induced block and delayed conduction as a mechanism for circus movement tachycardia in frog atria. Circ Res. 1989;64:213–26.

    Article  CAS  PubMed  Google Scholar 

  48. Francis GS. Should asymptomatic ventricular arrhythmias in patients with congestive heart failure be treated with antiarrhythmic drugs? J Am Coll Cardiol. 1988;12:274–83.

    Article  CAS  PubMed  Google Scholar 

  49. Wu CK, Tsai HY, Su MY, Wu YF, Hwang JJ, Tseng WY, et al. Pericardial fat is associated with ventricular tachyarrhythmia and mortality in patients with systolic heart failure. Atherosclerosis. 2015;241:607–14.

    Article  CAS  PubMed  Google Scholar 

  50. Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114:1500–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Oh S, Zhang Y, Bibevski S, Marrouche NF, Natale A, Mazgalev TN. Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. Heart Rhythm. 2006;3:701–8.

    Article  PubMed  Google Scholar 

  52. Nakagawa H, Scherlag BJ, Patterson E, Ikeda A, Lockwood D, Jackman WM. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm. 2009;6(12 Suppl):S26–34.

    Article  PubMed  Google Scholar 

  53. Pokushalov E, Kozlov B, Romanov A, Strelnikov A, Bayramova S, Sergeevichev D, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one year follow up of a randomized pilot study. Circ Arrhythm Electrophysiol. 2015;8:1334–41.

    Article  CAS  PubMed  Google Scholar 

  54. Couselo-Seijas M, López-Canoa JN, Agra-Bermejo RM, Díaz-Rodriguez E, Fernandez AL, Martinez-Cereijo JM, et al. Cholinergic activity regulates the secretome of epicardial adipose tissue: association with atrial fibrillation. J Cell Physiol. 2019;234(7):10512–22.

    Article  CAS  PubMed  Google Scholar 

  55. Yanagisawa S, Inden Y, Mizutani Y, Fujii A, Kamikubo Y, Kanzaki Y, et al. Vagal response in cryoballoon ablation of atrial fibrillation and autonomic nervous system: Utility of epicardial adipose tissue location. J Arrhythm. 2017;33(4):275–82.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Balcioğlu AS, Çiçek D, Akinci S, Eldem HO, Bal UA, Okyay K, Müderrisoğlu H. Arrhythmogenic evidence for epicardial adipose tissue: heart rate variability and turbulence are influenced by epicardial fat thickness. Pacing Clin Electrophysiol. 2015;38:99–106.

    Article  PubMed  Google Scholar 

  57. Kim MK, Tanaka K, Kim MJ, Matsuo T, Tomita T, Ohkubo H, et al. Epicardial fat tissue: relationship with cardiorespiratory fitness in men. Med Sci Sports Exerc. 2010;42:463–9.

    Article  PubMed  Google Scholar 

  58. Quan KJ, Lee JH, Van Hare GF, Biblo LA, Mackall JA, Carlson MD. Identification and characterization of atrioventricular parasympathetic innervation in humans. J Cardiovasc Electrophysiol. 2002;13:735–9.

    Article  PubMed  Google Scholar 

  59. Zhou Q, Zhang L, Wang K, Xu X, Ji M, Zhang F, et al. Effect of interconnection between cervical vagus trunk, epicardial fat pad on sinus node function, and atrial fibrillation. Pacing Clin Electrophysiol. 2014;37:356–63.

    Article  PubMed  Google Scholar 

  60. White CM, Sander S, Coleman CI, Gallagher R, Takata H, Humphrey C, et al. Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. J Am Coll Cardiol. 2007;49:298–303.

    Article  PubMed  Google Scholar 

  61. Burgeiro A, Fuhrmann A, Cherian S, Espinoza D, Jarak I, Carvalho RA, et al. Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes. Am J Physiol Endocrinol Metab. 2016;310:E550–64.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Katlandur H, Ozbek K, Keser A. Letter to the Editor: the effect of autonomic nervous system on the impairment of glucose uptake and lipid metabolism in epicardial adipose tissue. Am J Physiol Endocrinol Metab. 2016;310:E862.

    Article  PubMed  Google Scholar 

  63. White A. Cardiac sympathetic denervation in the failing heart: a role for epicardial adipose tissue. Circ Res. 2016;118(8):1189–91.

    Article  CAS  PubMed  Google Scholar 

  64. Parisi V, Rengo G, Perrone-Filardi P, Pagano G, Femminella GD, Paolillo S, et al. Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure. Circ Res. 2016;118(8):1244–53.

    Article  CAS  PubMed  Google Scholar 

  65. Iacobellis G, Leonetti F, Singh N, M Sharma A. Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol. 2007;115:272–3.

    Article  PubMed  Google Scholar 

  66. Iacobellis G, Singh N, Wharton S, Sharma AM. Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring). 2008;16:1693–7.

    Article  Google Scholar 

  67. Packer M. Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity. Circulation. 2018;137:1614–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA

    Celina M. Pollard, Jennifer Maning & Anastasios Lymperopoulos

Authors
  1. Celina M. Pollard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Maning
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anastasios Lymperopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anastasios Lymperopoulos .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA

    Gianluca Iacobellis

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pollard, C.M., Maning, J., Lymperopoulos, A. (2020). Autonomic Nervous System Modulation of the Epicardial Adipose Tissue in Heart Failure and Atrial Fibrillation. In: Iacobellis, G. (eds) Epicardial Adipose Tissue. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-40570-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-40570-0_12

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-40569-4

  • Online ISBN: 978-3-030-40570-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation